organization

TUMS

Tehran University of Medical Sciences
  • project . 2019 - 2023
    Funder: EC Project Code: 815622
    Funder Contribution: 3,753,140 EUR
    Open Access mandate for Publications and Research Data
    Partners: OBLITA THERAPEUTICS, UT, ST GEORGE'S HOSPITAL MEDICAL SCHOOL, LSHTM, Avivia Beheer BV, TUMS

    Cutaneous leishmaniasis (CL) is a poverty related, neglected tropical disease, which is without an effective and cheap systemic treatment. The aim of TT4CL is to develop a new orally available drug for treatment of CL aimed towards registration with stringent regulatory...

  • project . 2017 - 2021
    Funder: EC Project Code: 767325
    Overall Budget: 4,004,190 EURFunder Contribution: 4,004,190 EUR
    Open Access mandate for Publications
    Partners: URV, microLIQUID, Ghent University, FUNDICO, Medical University of Graz, Labman Automation Ltd, TUMS, Fraunhofer

    As a consequence of the ageing of the society, osteoporosis (literally “porous bone”) and its complications is becoming more and more prevalent, making the bone disease a health priority in many parts of the world. Currently osteoporosis is commonly known as a “silent k...

  • project . 2019 - 2022
    Funder: EC Project Code: 825771
    Overall Budget: 4,097,230 EURFunder Contribution: 3,153,450 EUR
    Open Access mandate for Publications and Research Data
    Partners: GERMAN CANCER RESEARCH CENTER, TUMS, UNITO, KLINIKUM DER UNIVERSITAET ZU KOELN, University of Glasgow, UBA, CLB, University of Bristol, Charles University, University of Tennessee System...

    Worldwide, more than 550,000 new cases of head and neck cancer (HNC) occur each year, resulting in approximately 300,000 deaths annually. It is the 6th most common cancer in both Europe and South America. A major reason for the high mortality rate for this cancer is the...

Any information missing or wrong?Report an Issue